News

Home >> News >> Page 23
A weak heart links to memory impairment
26.02.2021

A weak heart links to memory impairment

Heart problems cause disturbed gene activity in the brain’s memory center, from which cognitive deficits arise. A team led by Prof. Dr. André Fischer (reserach group leader at the DZNE Göttingen site, Professor at the Department of Psychiatry and Psychotherapy at the UMG and MBExC member) and Prof. Dr. Karl
Learn More
Communitas Prize for Viola Priesemann
18.02.2021

Communitas Prize for Viola Priesemann

The Max Planck Society honors the physicist and MBExC member Dr. Viola Priesemann for her science communication during the Corona pandemic, where she advises politicians, gives interviews, writes statements and publishes her scientific work in prestigious journals. Since the beginning of the pandemic, Viola Priesemann has been calculating scenarios of
Learn More
“Heart patch” made from stem cells enters world’s first clinical trial
09.02.2021

“Heart patch” made from stem cells enters world’s first clinical trial

First application in humans: The BioVAT-HF-DZHK20 study intends to investigate the use of heart muscle tissue derived from stem cells for treatment of patients with severe heart failure. The incorporation of heart muscle tissue cultivated in the laboratory is intended to sustainably improve the pumping function of diseased hearts. The
Learn More
Synaptic diversity broadens the range of sound we can hear
05.02.2021

Synaptic diversity broadens the range of sound we can hear

Hearing occurs when sensory hair cells in the inner ear convert sound into neural signals transmitted to the brain. The sensory hair cells have about a dozen communication points with the auditory nerve fibers, called synapses. Scientists from the Institute for Auditory Neuroscience at the University Medical Center Göttingen discovered
Learn More
Awarded doctorate in neuroscientific hearing research
05.02.2021

Awarded doctorate in neuroscientific hearing research

Dr. Alexander Dieter, a young neuroscientist and first author of the MBExC publication “μLED‐based optical cochlear implants for spectrally selective activation of the auditory nerve” (published in summer 2020 in the EMBO Molecular Medicine Journal), has been awarded with the doctoral thesis award 2021 of the Studienstiftung des Deutschen Volkes.
Learn More
The Hector Science Award goes to Patrick Cramer
02.02.2021

The Hector Science Award goes to Patrick Cramer

The Hector Foundation honors the director of the Max Planck Institute (MPI) for Biophysical Chemistry and member of the MBExC, Patrick Cramer, for his outstanding research in the field of gene transcription. The prize is endowed with 150,000 euros and was awarded at a virtual event on January 29.
Learn More
Alternative to cardiac catheter examination
29.01.2021

Alternative to cardiac catheter examination

Diastolic heart failure can be reliably detected with the help of a newly developed magnetic resonance imaging (MRI) technology, shows a study by the Göttingen partner site of the German Centre for Cardiovascular Research (DZHK). Until now, this was only possible with an invasive cardiac catheter examination, which is very
Learn More
Patrick Cramer receives the 2021 Louis-Jeantet Prize for Medicine
26.01.2021

Patrick Cramer receives the 2021 Louis-Jeantet Prize for Medicine

The research award is one of the most prestigious in Europe and endowed with 500,000 Swiss francs. With this prize the Louis-Jeantet Foundation honors the director at the Max Planck Institute (MPI) for Biophysical Chemistry and member of the MBExC for his pioneering work in the field of gene transcription.
Learn More
Carola Gregor and Antoine Huet are new MBExC Junior Fellows
25.01.2021

Carola Gregor and Antoine Huet are new MBExC Junior Fellows

The Cluster of Excellence “Multiscale Bioimaging” (MBExC) welcomes Dr. Carola Gregor and Dr. Antoine Huet as new Junior Fellows starting in January 2021 for 3 years. Dr. Carola Gregor will focus with her project Bioluminescence imaging of neurons and cardiomyocytes  on the bioluminescence system from bacteria to develop new tools
Learn More
Why remdesivir does not fully stop the coronavirus
18.01.2021

Why remdesivir does not fully stop the coronavirus

Remdesivir is the first drug against Covid-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral copying machine, called RNA polymerase. Researchers at the Max Planck Institute (MPI) for
Learn More
X
EN DE
X
X